{
    "nctId": "NCT04967976",
    "briefTitle": "Breast Mesh Used in Two-staged Breast Reconstruction",
    "officialTitle": "A Prospective Randomized and Controlled Study of Efficacy and Safety of TiLOOP\u00ae Bra Mesh in Patients With Expander-Implant Breast Reconstruction.",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Radiation, Breast Reconstruction, Synthetic Mesh",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Complication Rates",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Diagnosed with breast cancer\n2. More than 18 years old\n3. Karnofsky Performance Status (KPS) larger than 80\n4. No clinical or imaging evidence of distant metastasis\n5. BMI \\< 35kg/m2\n6. Patients with no or mild breast ptosis\n7. No severe deficiency in hematological, cardiovascular system, no immune-deficiency, no severe abnormal liver or kidney function.\n8. Mental Health Patient\n\n   -\n\n   Exclusion Criteria:\n\n1. Patients with distant metastasis of breast cancer or local recurrence; 2. Past ipsilateral breast/chest wall radiation; 3. Inflammatory breast cancer, stage IV breast cancer 4. History of severe allergic or specific constitution; 5. Mental illness; 6. Drug/alcohol abuse; 7. Pregnancy, lactation, or impregnated during the trial period; 8. Non-eligible to the study enrollment based on researchers' discretion\n\n-",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}